CERo Therapeutics Holdings, Inc. CERO
0.01 USD 0.00 (+25.00%)
At closeNov 3, 2026, 4:00 PM EST
0.12 +0.12 +2,348.00%
After hours · Nov 3, 4:00 PM ET
0.0038 Day range 0.005
0.003 52-week range 0.209
- YTD
- -92.54%
- 1 year
- -92.96%
Financial health
Altman Z-Score
-121.87 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.0×
FY 2021 5y median -17.5× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -0.1×
FY 2021 5y median -0.1× FY 2025
P/FCF -0.0×
FY 2021 5y median -27.9× FY 2025
EV/EBITDA 0.0×
FY 2021 5y median -1.9× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -5678.3%
FY 2021 5y median -3.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 365.7%
FY 2021 5y median 0.0% FY 2025
ROIC 388.9%
FY 2021 5y median -0.2% FY 2025
ROA -547.1%
FY 2021 5y median -1.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -20.7%
FY 2021 FY 2025
EPS (diluted) -228.7%
FY 2021 FY 2025
Free Cash Flow -177.7%
FY 2021 FY 2025
Financial Health
Current Ratio 0.3×
FY 2021 5y median 0.5× FY 2025
Quick Ratio 0.3×
FY 2021 5y median 0.5× FY 2025
Debt / Equity -0.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2021 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2021 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31